T Regulatory Cells in Allergen-Specific Immunotherapy

REFERENCES

• N. Novak, S. Kruse, J. Potreck, L. Maintz, C. Jenneck, S. Weidinger, R. Fimmers, and T. Bieber, Single nucleotide polymorphisms of the IL18 gene are associated with atopic eczema, J. Allergy Clin. Immunol., 115: 828–833, 2005. [CSA]
   PubMed Web of Science ®Google Scholar
• D.G. Contopoulos-Ioannidis, E.N. Manoli, and J.P. Ioannidis, Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes, J. Allergy Clin. Immunol., 115: 963–972, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P.S. Gao, R.A. Mathias, B. Plunkett, A. Togias, K.C. Barnes, T.H. Beaty, and S.K. Huang, Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population, J. Allergy Clin. Immunol., 115: 982–988, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. Zhang, E. Noguchi, O. Migita, Y. Yokouchi, J. Nakayama, M. Shibasaki, and T. Arinami, Association of a haplotype block spanning SDAD1 gene and CXC chemokine genes with allergic rhinitis, J. Allergy Clin. Immunol., 115: 548–554, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A. Saxon and D. Diaz-Sanchez, Air pollution and allergy: You are what you breathe, Nat. Immunol., 6: 223–226, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S.T. Remes, H.O. Koskela, K. Iivanainen, and J. Pekkanen, Allergen-specific sensitization in asthma and allergic diseases in children: The study on farmers' and non-farmers' children, Clin. Exp. Allergy, 35: 160–166, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.K. Williams, E.L. Peterson, M. Pladevall, K. Tunceli, D.R. Ownby, and C.C. Johnson, Timing and intensity of early fevers and the development of allergies and asthma, J. Allergy Clin. Immunol., 116: 102–108, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C.C. Johnson, D.R. Ownby, S.H. Alford, S.L. Havstad, L.K. Williams, E.M. Zoratti, E.L. Peterson, and C.L. Joseph, Antibiotic exposure in early infancy and risk for childhood atopy, J. Allergy Clin. Immunol., 115: 1218–1224, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R.W. Wells and M.G. Blennerhassett, The increasing prevalence of Crohn's disease in industrialized societies: The price of progress? Can. J. Gastroenterol., 19: 89–95, 2005. [CSA]
   PubMed Web of Science ®Google Scholar
• E.A. Gale, The rise of childhood type 1 diabetes in the 20th century, Diabetes, 51: 3353–3361, 2002. [CSA]
   PubMed Web of Science ®Google Scholar
• J.M. Vonk, D.S. Postma, H.M. Boezen, M.H. Grol, J.P. Schouten, G.H. Koeter, and J. Gerritsen, Childhood factors associated with asthma remission after 30 year follow up, Thorax, 59: 925–929, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.R. Karlsson, J. Rugtveit, and P. Brandtzaeg, Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy, J. Exp. Med., 199: 1679–1688, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D.I. Bernstein, M. Wanner, L. Borish, and G.M. Liss, Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001, J. Allergy Clin. Immunol., 113: 1129–1136, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W.W. Leitner and J. Thalhamer, DNA vaccines for non-infectious diseases: New treatments for tumour and allergy, Expert. Opin. Biol. Ther., 3: 627–638, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J.J. Donnelly, B. Wahren, and M.A. Liu, DNA vaccines: Progress and challenges, J. Immunol., 175: 633–639, 2005. [CSA]
   PubMed Web of Science ®Google Scholar
• M. Larche and D.C. Wraith, Peptide-based therapeutic vaccines for allergic and autoimmune diseases, Nat. Med., 11lpar;4 Suppl.): S69–76, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• U. Muller, C.A. Akdis, M. Fricker, M. Akdis, T. Blesken, F. Bettens, and K. Blaser, Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom, J. Allergy Clin. Immunol., 101(6 Pt 1): 747–754, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A.C. Drew, N.P. Eusebius, L. Kenins, H.D. de Silva, C. Suphioglu, J.M. Rolland, and R.E. O'Hehir, Hypoallergenic variants of the major latex allergen Hev b 6.01 retaining human T lymphocyte reactivity, J. Immunol., 173: 5872–5879, 2004. [CSA]
   PubMed Web of Science ®Google Scholar
• T.R. Smith, C. Alexander, A.B. Kay, M. Larche, and D.S. Robinson, Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: A double-blind placebo-controlled study, Allergy, 59: 1097–1101, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C.L. Zuleger, X. Gao, M.S. Burger, Q. Chu, L.G. Payne, and D. Chen, Peptide induces CD4(+)CD25+ and IL-10+ T cells and protection in airway allergy models, Vaccine, 23: 3181–3186, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. Focke, B. Linhart, A. Hartl, U. Wiedermann, W.R. Sperr, P. Valent, J. Thalhamer, D. Kraft, and R. Valenta, Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination, Clin. Exp. Allergy, 34: 1525–1533, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• F. Kussebi, F. Karamloo, C. Rhyner, P. Schmid-Grendelmeier, M. Salagianni, C. Mannhart, M. Akdis, L. Soldatova, Z. Markovic-Housley, B.R. Von Beust, , et al, A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy, J. Allergy Clin. Immunol., 115: 323–329, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.K. Levings, R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M.G. Roncarolo, IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells, J. Immunol., 166: 5530–5539, 2001. [CSA]
   PubMed Web of Science ®Google Scholar
• H. Groux, A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. de Vries, and M.G. Roncarolo, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389: 737–742, 1997. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• F.J. Barrat, D.J. Cua, A. Boonstra, D.F. Richards, C. Crain, H.F. Savelkoul, R. de Waal-Malefyt, R.L. Coffman, C.M. Hawrylowicz, and A. O'Garra, In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines, J. Exp. Med., 195: 603–616, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• F. Cottrez, S.D. Hurst, R.L. Coffman, and H. Groux, T regulatory cells 1 inhibit a Th2-specific response in vivo, J. Immunol., 165: 4848–4853, 2000. [CSA]
   PubMed Web of Science ®Google Scholar
• M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, , et al, Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells, J. Exp. Med., 199: 1567–1575, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. Jutel, M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, K. Blaser, and C. Akdis, IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy, Eur. J. Immunol., 33: 1205–1214, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J.N. Francis, S.J. Till, and S.R. Durham, Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy, J. Allergy Clin. Immunol., 111: 1255–1261, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J. Immunol., 155: 1151–1164, 1995. [CSA]
   PubMed Web of Science ®Google Scholar
• J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat. Immunol., 4: 330–336, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• E.M. Ling, T. Smith, X.D. Nguyen, C. Pridgeon, M. Dallman, J. Arbery, V.A. Carr, and D.S. Robinson, Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease, Lancet, 363: 608–615, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• T.A. Chatila, F. Blaeser, N. Ho, H.M. Lederman, C. Voulgaropoulos, C. Helms, and A.M. Bowcock, JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome, J. Clin. Invest., 106: R75–81, 2000. [CSA]
   PubMed Web of Science ®Google Scholar
• A. Cavani, F. Nasorri, C. Ottaviani, S. Sebastiani, O. De Pita, and G. Girolomoni, Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals, J. Immunol., 171: 5760–5768, 2003. [CSA]
   PubMed Web of Science ®Google Scholar
• B.J. Prakken, R. Samodal, T.D. Le, F. Giannoni, G.P. Yung, J. Scavulli, D. Amox, S. Roord, I. de Kleer, D. Bonnin, , et al, Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis, Proc. Natl. Acad. Sci. U. S. A., 101: 4228–4233, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D.J. Mekala, R.S. Alli, and T.L. Geiger, IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes, Proc. Natl. Acad. Sci. U. S. A., 102: 11817–11822, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C.A. Akdis, T. Blesken, M. Akdis, B. Wuthrich, and K. Blaser, Role of interleukin 10 in specific immunotherapy, J. Clin. Invest., 102: 98–106, 1998. [CSA]
   PubMed Web of Science ®Google Scholar
• C.A. Akdis, M. Akdis, T. Blesken, D. Wymann, S.S. Alkan, U. Muller, and K. Blaser, Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro, J. Clin. Invest., 98: 1676–1683, 1996. [CSA]
   PubMed Web of Science ®Google Scholar
• C.A. Akdis, A. Joss, M. Akdis, A. Faith, and K. Blaser, A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding, FASEB J., 14: 1666–1669, 2000. [CSA]
   PubMed Web of Science ®Google Scholar
• C. Walker, J.-C. Virchow, P.L.B. Bruijnzeel, and K. Blaser, T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma, J. Immunol., 146: 1829–1835, 1991. [CSA]
   PubMed Web of Science ®Google Scholar
• R.P. Schleimer, C.P. Derse, B. Friedman, S. Gillis, M. Plaut, L.M. Lichtenstein, and D.W. MacGlashan Jr., Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids, J. Immunol., 143: 1310–1327, 1989. [CSA]
   PubMed Web of Science ®Google Scholar
• S. Treter and M. Luqman, Antigen-specific T cell tolerance down-regulates mast cell responses in vivo, Cell. Immunol., 206: 116–124, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y.K. Shim, B.S. Kim, S.H. Cho, K.U. Min, and S.J. Hong, Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability, Clin. Exp. Allergy, 33: 52–57, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L. Borish, A. Aarons, J. Rumbyrt, P. Cvietusa, J. Negri, and S. Wenzel, Interleukin-10 regulation in normal subjects and patients with asthma, J. Allergy Clin. Immunol., 97: 1288–1296, 1996. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H. Koning, H.J. Neijens, M.R. Baert, A.P. Oranje, and H.F. Savelkoul, T cells subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production, Cytokine, 9: 427–436, 1997. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J.O. Lindsay, C.J. Ciesielski, T. Scheinin, H.J. Hodgson, and F.M. Brennan, The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10, J. Immunol., 166: 7625–7633, 2001. [CSA]
   PubMed Web of Science ®Google Scholar
• L. Steidler, S. Neirynck, N. Huyghebaert, V. Snoeck, A. Vermeire, B. Goddeeris, E. Cox, J.P. Remon, and E. Remaut, Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10, Nat. Biotechnol., 21: 785–789, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W. Scherf, S. Burdach, and G. Hansen, Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model, Eur. J. Immunol., 35: 198–206, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• O. Fainaru, D. Shseyov, S. Hantisteanu, and Y. Groner, Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease, Proc. Natl. Acad. Sci. U. S. A., 102: 10598–10603, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C.P. Frossard, C. Hauser, and P.A. Eigenmann, Antigen-specific secretory IgA antibodies in the gut are decreased in a mouse model of food allergy, J. Allergy Clin. Immunol., 114: 377–382, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S. Huber, C. Schramm, H.A. Lehr, A. Mann, S. Schmitt, C. Becker, M. Protschka, P.R. Galle, M.F. Neurath, and M. Blessing, Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells, J. Immunol., 173: 6526–6531, 2004. [CSA]
   PubMed Web of Science ®Google Scholar
• J.C. Marie, J.J. Letterio, M. Gavin, and A.Y. Rudensky, TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells, J. Exp. Med., 201: 1061–1067, 2005. [CSA]
   PubMed Web of Science ®Google Scholar
• S. You, M. Belghith, S. Cobbold, M.A. Alyanakian, C. Gouarin, S. Barriot, C. Garcia, H. Waldmann, J.F. Bach, and L. Chatenoud, Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells, Diabetes, 54: 1415–1422, 2005. [CSA]
   PubMed Web of Science ®Google Scholar
• J.P. Allam, E. Klein, T. Bieber, and N. Novak, Transforming growth factor-beta1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro, J. Invest. Dermatol., 123: 676–682, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P.W. Hellings, P. Vandenberghe, A. Kasran, L. Coorevits, L. Overbergh,C. Mathieu, and J.L. Ceuppens, Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice, Eur. J. Immunol., 32: 585–594, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. Jutel, T. Watanabe, S. Klunker, M. Akdis, O.A. Thomet, J. Malolepszy,T. Zak-Nejmark, R. Koga, T. Kobayashi, K. Blaser, , et al, Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors, Nature, 413: 420–425, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C.A. Akdis and K. Blaser, Histamine in the immune regulation of allergic inflammation, J. Allergy Clin. Immunol., 112: 15–22, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• G. Caron, Y. Delneste, E. Roelandts, C. Duez, J.Y. Bonnefoy, J. Pestel, and P. Jeannin, Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells, J. Immunol., 167: 3682–3686, 2001. [CSA]
   PubMed Web of Science ®Google Scholar
• A. Mazzoni, H.A. Young, J.H. Spitzer, A. Visintin, and D.M. Segal, Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization, J. Clin. Invest., 108: 1865–1873, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• N. Osna, K. Elliott, and M.M. Khan, Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes, Int. Immunopharmacol., 1: 85–96, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S. Kunzmann, P.Y. Mantel, J.G. Wohlfahrt, M. Akdis, K. Blaser, and C.B. Schmidt-Weber, Histamine enhances TGF-beta1-mediated suppression of Th2 responses, FASEB J., 17: 1089–1095, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. Benovic, Novel β2-adrenergic receptor signaling pathways, J. Allergy Clin. Immunol., 110: s229-s235, 2002. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• E. Goleva, A. Dunlap, and D.Y. Leung, Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists, J. Allergy Clin. Immunol., 114: 183–191, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar